THE increasing enthusiasm for treating thromboembolic diseases with prothrombin-reducing drugs for long periods in ambulatory patients has emphasized the lack of clear definition of the therapeutic ...
Recently, another modified one-stage method, developed by Owren, 7 has been given the distinctive name of thrombotest. Claims have been made that this test is more satisfactory for controlling ...
Do patients with renal disease have inherent coagulopathy? What prothrombin time (PT)/partial thromboplastin time (PTT) values can be expected with end-stage renal disease (ESRD)? —OMEL FIGUEROA, PA-C ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results